This month the Department of Government Efficiency (DOGE) published new estimates of "savings" from various regulatory changes, which it says total $29.4 billion so far. The New York Times suggests several reasons to question these numbers but overlooks the most fundamental problem: Although deregulation accounts for about 17 percent of the $175 billion in total "estimated savings" that DOGE claims, the numbers in this category generally have nothing to do with federal spending, the project's ostensible target.
One possible exception: DOGE claims changes to the rules governing health insurance subsidies under the Patient Protection and Affordable Care Act will save $10 billion, and at least some of that may represent reduced federal spending. But according to an "unnamed senior administration official" quoted by the Times, DOGE's estimates of the impact from regulatory changes "represent cost savings for regulated parties."
DOGE plausibly claims deregulation will reduce costs for businesses, and it may also benefit consumers in various ways. But those benefits have no impact on the annual budget deficit or the accumulating national debt. It is therefore illogical to include such "regulatory savings" in a tally that is supposed to show how far DOGE has gone in tackling those problems.
